Vincent Remouchamps
Radiation oncology
Dr. Vincent Remouchamps MD, PhD
CHU UCL Namur, Site Sainte-Elisabth, Department of Radiation Oncology
Researchgate | LinkedIn | ORCID
Expertise and research interests
Breast cancer - Lung cancer - Hematological malignancies
Research projects
- ProCaLung - Project on Cancer of the Lung. Clinical study. Sponsor: Jules Bordet Institute. 2021-2025.
- Loco-regional adjuvant radiotherapy for breast cancer: Retrospective analysis of hypofractionation according to the FAST scheme. Master thesis in biomedical sciences by Eléonore Brahy, UNamur, defended on 20/01/2023. Promoter: Dr. Vincent Remouchamps
- Loco-regional adjuvant radiotherapy for breast cancer: Retrospective analysis of the toxicity and impact of the Covid-19 pandemic. Master thesis in biomedical sciences by Julinne Stokart, UNamur, defended on 20/01/2023. Promoter: Dr. Vincent Remouchamps
Selected publications
Lievens Y, Janssens S, Lambrecht M, Engels H, Geets X, Jansen N, Moretti L, Remouchamps V, Roosens S, Stellamans K, Verellen D, Weltens C, Weytjens R, Van Damme N; Belgian College for Physicians of Radiation Oncology Centres. Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013-2019): a nationwide registry-based prospective study. Lancet Reg Health Eur. 2024 Jul 6;44:100992.
Mauclet C, Dupont MV, Roelandt K, Regnier M, Delos M, Pirard L, Vander Borght T, Dahlqvist C, Froidure A, Rondelet B, Vanderick J, Remouchamps V, Duplaquet F, Ocak S. Treatment and Prognosis of Patients with Lung Cancer and Combined Interstitial Lung Disease. Cancers (Basel). 2023 Jul 30;15(15):3876.
Vaandering A, Jansen N, Weltens C, Moretti L, Stellamans K, Vanhoutte F, Scalliet P, Remouchamps V, Lievens Y; Belgian College for Physicians in Radiation Oncology. Radiotherapy-specific quality indicators at national level: How to make it happen. Radiother Oncol. 2023 Jan;178:109433.
Benkhaled S, Koshariuk O, Van Esch A, Remouchamps V. Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value? Rep Pract Oncol Radiother. 2022 Jul 29;27(3):490-499.
Dubaere E, Goffaux M, Wanet M, Bihin B, Gheldof C, Demoulin AS, Bolly A, Bustin F, Duplaquet F, Baugnee PE, Gustin M, Hers V, Maisin F, Marchand E, Ocak S, Pirard L, Vancutsem O, Van Neck E, Vandermoten G, Zaharia L, Remouchamps V. Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer. BMC Cancer. 2019 Jun 28;19(1):639.
Ledoux B, Dupont M, Duplaquet F, Pirard L, Ocak S, Wanet M, Remouchamps V. Illustration of a fatal radiation-induced lung aneurysm: Is central lung stereotactic radiotherapy to be banned? Cancer Radiother. 2019 Oct 11.
Remouchamps VM, Huyskens DP, Mertens I, Destine M, Van Esch A, Salamon E, De Neve W. The use of magnetic sensors to monitor moderate deep inspiration breath hold during breast irradiation with dynamic MLC compensators. Radiother Oncol. 2007 Mar;82(3):341-8.
Remouchamps VM, Letts N, Vicini FA, Sharpe MB, Kestin LL, Chen PY, Martinez AA, Wong JW. Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):704-15.
Remouchamps VM, Letts N, Yan D, Vicini FA, Moreau M, Zielinski JA, Liang J, Kestin LL, Martinez AA, Wong JW. Three-dimensional evaluation of intra- and interfraction immobilization of lung and chest wall using active breathing control: a reproducibility study with breast cancer patients. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):968-78.
Remouchamps VM, Vicini FA, Sharpe MB, Kestin LL, Martinez AA, Wong JW. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):392-406.